Opus Genetics, Inc. IRD
3.93 USD +0.23 (+6.22%)
At closeNov 4, 2026, 8:21 AM EST
3.94 +0.01 +0.25%
Pre-market · Nov 4, 8:21 AM ET
3.74 Day range 3.99
1.70 52-week range 7.07
- YTD
- +95.52%
- 1 year
- +81.11%
Financial health
Altman Z-Score
-4.62 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.5×
FY 2019 5y median -0.6× FY 2025
P/S 88.1×
FY 2019 5y median 2.9× FY 2025
P/B 81.5×
FY 2019 5y median 0.9× FY 2025
P/FCF -35.5×
FY 2019 5y median -1.2× FY 2025
EV/EBITDA -25.1×
FY 2019 5y median -0.0× FY 2025
EV/Sales 84.9×
FY 2019 5y median -0.4× FY 2025
FCF Yield -2.8%
FY 2019 5y median -4.0% FY 2025
Profitability
Gross Margin 100.0%
FY 2019 5y median 100.0% FY 2025
Operating Margin -271.9%
FY 2019 5y median -271.9% FY 2025
Net Margin -349.3%
FY 2019 5y median -349.3% FY 2025
ROE -323.1%
FY 2019 5y median -255.1% FY 2025
ROIC -90.9%
FY 2019 5y median -90.9% FY 2025
ROA -98.7%
FY 2019 5y median -98.7% FY 2025
Growth (YoY)
Revenue 29.1%
FY 2019 FY 2025
Operating Income 37.8%
FY 2019 FY 2025
EPS (diluted) 62.8%
FY 2019 FY 2025
Free Cash Flow -37.8%
FY 2019 FY 2025
Financial Health
Current Ratio 6.4×
FY 2019 5y median 6.8× FY 2025
Quick Ratio 6.4×
FY 2019 5y median 6.8× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2019 5y median 0.5× FY 2025
Interest Coverage -26.3×
FY 2019 5y median -8.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31